BRPI0417218A - usos farmacêuticos de bisfosfonatos - Google Patents
usos farmacêuticos de bisfosfonatosInfo
- Publication number
- BRPI0417218A BRPI0417218A BRPI0417218-3A BRPI0417218A BRPI0417218A BR PI0417218 A BRPI0417218 A BR PI0417218A BR PI0417218 A BRPI0417218 A BR PI0417218A BR PI0417218 A BRPI0417218 A BR PI0417218A
- Authority
- BR
- Brazil
- Prior art keywords
- bisphosphonates
- effective amount
- patient
- pharmaceutical uses
- taxol
- Prior art date
Links
- 229940122361 Bisphosphonate Drugs 0.000 title abstract 4
- 150000004663 bisphosphonates Chemical class 0.000 title abstract 4
- 229930012538 Paclitaxel Natural products 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 230000003211 malignant effect Effects 0.000 abstract 2
- 229960001592 paclitaxel Drugs 0.000 abstract 2
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 abstract 2
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 229940127089 cytotoxic agent Drugs 0.000 abstract 1
- HPJKCIUCZWXJDR-UHFFFAOYSA-N letrozole Chemical class C1=CC(C#N)=CC=C1C(N1N=CN=C1)C1=CC=C(C#N)C=C1 HPJKCIUCZWXJDR-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0328040.1A GB0328040D0 (en) | 2003-12-03 | 2003-12-03 | Pharmaceutical uses of bisphosphonates |
| PCT/EP2004/013728 WO2005053709A2 (en) | 2003-12-03 | 2004-12-02 | Pharmaceutical uses of bisphosphonates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0417218A true BRPI0417218A (pt) | 2007-02-21 |
Family
ID=29764511
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0417218-3A BRPI0417218A (pt) | 2003-12-03 | 2004-12-02 | usos farmacêuticos de bisfosfonatos |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20070219115A1 (https=) |
| EP (1) | EP1691816A2 (https=) |
| JP (1) | JP2007513118A (https=) |
| KR (1) | KR20060130052A (https=) |
| CN (2) | CN101669958A (https=) |
| AU (1) | AU2004294713B2 (https=) |
| BR (1) | BRPI0417218A (https=) |
| CA (1) | CA2546782A1 (https=) |
| GB (1) | GB0328040D0 (https=) |
| RU (1) | RU2006123423A (https=) |
| WO (1) | WO2005053709A2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2332636B1 (es) * | 2008-08-06 | 2011-02-10 | Universitat De Les Illes Balears | Composicion de liquido de dialisis. |
| WO2011133687A2 (en) * | 2010-04-20 | 2011-10-27 | President And Fellows Of Harvard College | Methods and compositions for inhibition of beta2-adrenergic receptor degradation |
| CN102961785A (zh) * | 2012-11-09 | 2013-03-13 | 于秀淳 | 一种用于治疗骨巨细胞瘤的瘤腔填充物及其制备方法 |
| AU2018445164B2 (en) | 2018-10-11 | 2025-05-29 | Vifor (International) Ltd. | Inositol phosphates for the treatment of ectopic calcification |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK288365B6 (sk) * | 1999-02-10 | 2016-07-01 | Astrazeneca Ab | Medziprodukty pre chinazolínové deriváty ako inhibítory angiogenézy |
| BR0213410A (pt) * | 2001-10-19 | 2004-11-03 | Novartis Ag | Usos farmacêuticos de bisfosfonatos |
| AU2003250190A1 (en) * | 2002-07-30 | 2004-02-23 | Novartis Ag | Combination of an aromatase inhibitor with a bisphosphonate |
-
2003
- 2003-12-03 GB GBGB0328040.1A patent/GB0328040D0/en not_active Ceased
-
2004
- 2004-12-02 CA CA002546782A patent/CA2546782A1/en not_active Abandoned
- 2004-12-02 BR BRPI0417218-3A patent/BRPI0417218A/pt not_active IP Right Cessation
- 2004-12-02 RU RU2006123423/15A patent/RU2006123423A/ru not_active Application Discontinuation
- 2004-12-02 US US10/578,290 patent/US20070219115A1/en not_active Abandoned
- 2004-12-02 CN CN200910161293A patent/CN101669958A/zh active Pending
- 2004-12-02 KR KR1020067010798A patent/KR20060130052A/ko not_active Ceased
- 2004-12-02 WO PCT/EP2004/013728 patent/WO2005053709A2/en not_active Ceased
- 2004-12-02 CN CNA2004800360730A patent/CN1889962A/zh active Pending
- 2004-12-02 EP EP04803464A patent/EP1691816A2/en not_active Withdrawn
- 2004-12-02 AU AU2004294713A patent/AU2004294713B2/en not_active Ceased
- 2004-12-02 JP JP2006541901A patent/JP2007513118A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP1691816A2 (en) | 2006-08-23 |
| WO2005053709A2 (en) | 2005-06-16 |
| CN101669958A (zh) | 2010-03-17 |
| WO2005053709A3 (en) | 2006-01-05 |
| US20070219115A1 (en) | 2007-09-20 |
| AU2004294713A1 (en) | 2005-06-16 |
| RU2006123423A (ru) | 2008-01-20 |
| CA2546782A1 (en) | 2005-06-16 |
| AU2004294713B2 (en) | 2009-04-30 |
| CN1889962A (zh) | 2007-01-03 |
| JP2007513118A (ja) | 2007-05-24 |
| KR20060130052A (ko) | 2006-12-18 |
| GB0328040D0 (en) | 2004-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0116370A (pt) | Composto, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada por hppar em um paciente. | |
| BRPI0516177A (pt) | oligorribonucleotìdios e métodos para uso dos mesmos para o tratamento da alopécia, insuficiência renal aguda e outras doenças | |
| BR0115109A (pt) | Agentes terapêuticos e métodos de uso dos mesmos para a modulação da angiogênese | |
| BR0310099A (pt) | método para tratar dislipidemia ou uma doença associada com a dislipidemia | |
| CY1107074T1 (el) | Συνθεση εναντιομερων 4-αμινο-θαλιδομιδης | |
| BR0015974A (pt) | Uso de levetiracetam, composição farmacêutica, uso de uma composição farmacêutica e métodos para tratar um paciente admintstrado com uma quantidade de pelo menos um composto e uma doença e para potenciar seletivamente o efeito terapêutico de um composto | |
| CR8411A (es) | Metodo para el tratamiento de la enfermedad asociada con adamts-5 | |
| BR9814923A (pt) | Método para tratamento de doença de alzheimer | |
| BR0114310A (pt) | Derivados do glicopiranosiloxibenzilbenzeno e composições medicinais contendo os mesmos | |
| BR9815442A (pt) | Liberação terapêutica dirigida de compostos de vitamina d | |
| BRPI0512220A (pt) | método para tratamento, prevenção ou melhora de uma doença ou distúrbio; composição farmacêutica; processo para a preparação de um composto; e uso de um composto | |
| BR0215168A (pt) | Métodos para retardar a senescência e tratamento e prevenção de doenças associadas com senescência | |
| NO20034204D0 (no) | Farmasöytiske kombinasjoner til behandling av kreft | |
| BR0315580A (pt) | Derivados de metileno uréia | |
| DE69940951D1 (de) | Nd wachstumshemmende mittel | |
| CY1105788T1 (el) | Χρηση του taci σαν παραγοντα καταπολεμησης ογκων | |
| BRPI0414500A (pt) | formulação farmacêutica composição para tratar uma infecção vaginal, e, métodos para tratar uma infecção vaginal, para estabilizar uma formulação de clindamicina, para tratar ou prevenir uma recorrência de uma infecção vaginal em uma paciente e para tratar condições vaginais | |
| BRPI0409796A (pt) | uso de dipiridamol ou mopidamol para tratamento e prevenção de doenças tromboembolìticas e distúrbios provocados pela formação excessiva de trombina e/ou pela expressão elevada de receptores de trombina | |
| BR0316523A (pt) | Composto, composição farmacêutica e método para tratar ou prevenir câncer em um paciente | |
| BR0010515A (pt) | Sistema terapêutico de ministração transdérmica, processo para mascarar um odor desagrádavel e uso de um óleo essencial em um sistema terapéutico de ministração transdérmica | |
| BR0201524A (pt) | Tratamento de combinação para ansiedade e depressão | |
| EP2170878A4 (en) | NEW BENZAMIDINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF OSTEOPOROSIS CONTAINING THEM | |
| WO2004073615A3 (en) | Deazaflavin compounds and methods of use thereof | |
| BRPI0417218A (pt) | usos farmacêuticos de bisfosfonatos | |
| DK1237562T3 (da) | Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012. |